Stock Market Wire News Logo
Stock Market Wire News Logo
    • Login
    • Sign Up
stock market news, nxgen brands inc acquires exclusive license to utili 8386653890827187

RETA Quote, Trading Chart, Reata Pharmaceuticals Inc.


home / stock / reta / reta quote

$110.17 Last:

0.15% Change Percent:

$111 Open:

$110.17 Previous Close:

$111 High:

$106.83 Low:

152,252 Volume:

01/21/2021 03:26:10 pm Last Trade Date Time:

Quotes are delayed by 15 to 20 minutes.

Last Five Trading Days

Stock DateOpen PriceClose PriceHighLowVolume
2021-01-21111110.17111106.83152,252
2021-01-20114.12110115.82109.7299,697
2021-01-19114.85113.84117.75112.22311,743
2021-01-18120.98111.93121.715111.8399,079
2021-01-15120.98111.93121.715111.8398,827
2021-01-14120.88120122.89119.46204,018
2021-01-13126.59121.27127.9120.78159,608
2021-01-12127.94125.96130.43124.52177,635
2021-01-11120.42126.51129.87119.95352,639
2021-01-08126.22120.51129.42118.34409,719
2021-01-07114.15125126.12114.06312,562
2021-01-06117.52113.1118.43112.01359,275
2021-01-05121.55118.6121.98116.95236,065
2021-01-04122.56121.29124.03119.65153,497
2021-01-01124.82123.62125.45121.5525178,968
2020-12-31124.82123.62125.45121.5525178,941
2020-12-30130.14125.01131.22124.365250,603
2020-12-29129.07129.73130.465124.64258,208
2020-12-28134.11129.3135.58128.2009319,677
2020-12-25127.32132.55133.2126.8048212,811
Stock Information

Reata Pharmaceuticals Inc. Company Name:

RETA Stock Symbol:

NASDAQ Market:

Reata Pharmaceuticals Inc. Website:

RETA Quote, Trading Chart, Reata Pharmaceuticals Inc.

MENU
RETA RETA Quote RETA Short RETA News RETA Articles RETA Message Board
Get RETA Alerts

News, Short Squeeze, Breakout and More Instantly...

stock market news, nxgen brands inc acquires exclusive license to utili 8386653890827187
RECENT RETA NEWS
  • RETA - Reata Pharmaceuticals, Inc. Announces Closing of Class A Common Stock Offering

    PLANO, Texas, Dec. 04, 2020 (GLOBE NEWSWIRE) -- Reata Pharmaceuticals, Inc. (Nasdaq: RETA) (“Reata” or the “Company”), a clinical-stage biopharmaceutical company, today announced the closing of its previously announced underwritten public offering of 2,000,00...

  • RETA - Reata Pharmaceuticals, Inc. Announces Pricing of Class A Common Stock Offering

    PLANO, Texas, Dec. 01, 2020 (GLOBE NEWSWIRE) -- Reata Pharmaceuticals, Inc. (Nasdaq: RETA) (“Reata” or the “Company”), a clinical-stage biopharmaceutical company, today announced that it has priced a public offering of 2,000,000 shares by the Company of its Class...

  • RETA - Reata Provides Update on Omaveloxolone Program for Patients with Friedreich's Ataxia

    PLANO, Texas, Nov. 24, 2020 (GLOBE NEWSWIRE) -- Reata Pharmaceuticals, Inc. (Nasdaq: RETA) (“Reata,” the “Company,” or “we”), a clinical-stage biopharmaceutical company, today announced that the U.S. Food and Drug Administration (“FDA”...

  • Research
  • Stock Search
  • News Releases
  • Articles
  • Message Boards
  • Trending Stocks
  • Short Information
  • Stock Wall
  • Member Benefits
  • Member Coins
  • Sign Up
  • Login
  • Contact
x
stock market news, nxgen brands inc acquires exclusive license to utili 8386653890827187

Important Investor Video Alert (OTCMKTS: NXGB)

  • NXGB - NxGen Brands, Inc. Acquires Exclusive License To Utilize & Market Various High Demand Technologies

    NxGen Brands, Inc. Acquires Exclusive License To Utilize & Market Various High Demand Technologies NxGen Brands, Inc. Acquires Exclusive License To Utilize & Market Various High Demand Technologies The Technology Largely Involves Advanced GPS Tracking And Associated ...

Sign up or login to continue

Sign up or login to continue.




WATCH LIVE TRENDING STOCKS

Advertise

Brand your company, advertise your products or services with our ad programs.

Advertise

Research

Stock Search

News Releases

Articles

Message Boards

Trending Stocks

Short Information

Stock Wall

Members

Member Benefits

Member Coins


Log In

Sign Up

Stay Connected
Follow @marketWN

Contact

Privacy

Terms of Service

Disclaimer

© 2020 Market Wire News